Location History:
- Santa Clara, CA (US) (2018)
- San Jose, CA (US) (2018)
- Tokyo, JP (2019 - 2020)
Company Filing History:
Years Active: 2018-2020
Title: Innovations of Kensuke Murata
Introduction
Kensuke Murata is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in transdermal delivery systems. With a total of five patents to his name, Murata's work focuses on innovative methods to enhance the effectiveness of therapeutic agents.
Latest Patents
One of Murata's latest patents is titled "Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same." This patent provides formulations that include a sphingosine-1-phosphate receptor agonist active agent combined with a topical delivery vehicle, such as a patch. The formulations aim to deliver therapeutically effective amounts of the active agent to treat conditions like multiple sclerosis and psoriasis. Another notable patent is "Rivastigmine transdermal compositions and methods of using the same." This patent details transdermal compositions that include rivastigmine and a solubility modulator, along with methods for their application.
Career Highlights
Kensuke Murata is currently associated with Teikoku Pharma USA, Inc., where he continues to innovate in the field of drug delivery systems. His work has been instrumental in developing new therapeutic options for patients with various medical conditions.
Collaborations
Murata collaborates with several professionals in his field, including Adchara Pongpeerapat and Bret Berner. These collaborations enhance the research and development of effective pharmaceutical solutions.
Conclusion
Kensuke Murata's contributions to pharmaceutical innovations, particularly in transdermal delivery systems, highlight his role as a leading inventor in the industry. His patents reflect a commitment to improving patient care through advanced therapeutic formulations.